FindMyKOL
Clinical trialNCT05369416Active, not recruitingInterventional

Renal Metabolism in Salt-sensitive Human Blood Pressure

NCT05369416 is an interventional trial sponsored by Medical College of Wisconsin. As of 21 Nov 2026, it is active and no longer recruiting. It studies Hypertension. The registry lists an enrollment of 70 participants at 1 site in 1 country. The registry lists a start date of 1 Nov 2021 and a primary completion date of 30 Jan 2030.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT05369416
FieldValue
Registry IDNCT05369416
StatusActive not recruiting
Study typeInterventional trial
Lead sponsorMedical College of Wisconsin
Enrollment70
Registered sites1
Countries1
ConditionsHypertension
Start1 Nov 2021
Primary completion30 Jan 2030
Study completion30 Jan 2030
Last update posted13 Nov 2025

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Salt sensitive hypertension is a significant health problem worldwide and a primary modifiable risk factor for renal, cardiovascular, and cerebrovascular diseases. Yet, the underlying mechanisms remain poorly understood. The proposed study determines how renal oxygenation and substrate metabolism differs between individuals with and without salt sensitivity, with the ultimate goal of identifying mechanisms, diagnostic criteria, and treatment strategies for salt sensitive hypertension.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Wisconsin, United States1 site
  • Medical College of Wisconsin /froedtert Hospital

    Milwaukee

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsin: 1 siteWI1MichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT05369416

Each answer restates registry values shown on this page.

What is NCT05369416?

NCT05369416 is an interventional trial sponsored by Medical College of Wisconsin. It studies Hypertension.

Is NCT05369416 recruiting?

As of 21 Nov 2026, it is active and no longer recruiting.

Who leads NCT05369416?

The registry names Srividya Kidambi, MD (principal investigator, Medical College of Wisconsin) as the overall official.

Where does NCT05369416 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT05369416 expected to complete?

The registry lists a primary completion date of 30 Jan 2030 and a study completion date of 30 Jan 2030. The sponsor last updated the record on 13 Nov 2025.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.